These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30853252)

  • 1. Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox.
    Chan-Tack KM; Harrington PR; Choi SY; Myers L; O'Rear J; Seo S; McMillan D; Ghantous H; Birnkrant D; Sherwat AI
    Lancet Infect Dis; 2019 Jun; 19(6):e221-e224. PubMed ID: 30853252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tecovirimat: First Global Approval.
    Hoy SM
    Drugs; 2018 Sep; 78(13):1377-1382. PubMed ID: 30120738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development and approval of tecoviromat (TPOXX
    Merchlinsky M; Albright A; Olson V; Schiltz H; Merkeley T; Hughes C; Petersen B; Challberg M
    Antiviral Res; 2019 Aug; 168():168-174. PubMed ID: 31181284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation.
    Chan-Tack K; Harrington P; Bensman T; Choi SY; Donaldson E; O'Rear J; McMillan D; Myers L; Seaton M; Ghantous H; Cao Y; Valappil T; Birnkrant D; Struble K
    Antiviral Res; 2021 Nov; 195():105182. PubMed ID: 34582915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.
    Duraffour S; Andrei G; Snoeck R
    IDrugs; 2010 Mar; 13(3):181-91. PubMed ID: 20191435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectre of smallpox lingers.
    Nature; 2018 Aug; 560(7718):281. PubMed ID: 30104592
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.
    Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox).
    Mucker EM; Goff AJ; Shamblin JD; Grosenbach DW; Damon IK; Mehal JM; Holman RC; Carroll D; Gallardo N; Olson VA; Clemmons CJ; Hudson P; Hruby DE
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6246-53. PubMed ID: 24100494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tecovirimat for smallpox infections.
    Bolken TC; Hruby DE
    Drugs Today (Barc); 2010 Feb; 46(2):109-17. PubMed ID: 20393639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Approved to Treat Smallpox After a Bioterrorist Attack.
    Aschenbrenner DS
    Am J Nurs; 2018 Nov; 118(11):21. PubMed ID: 30358593
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecule of the month. Tecovirimat.
    Drug News Perspect; 2008 Nov; 21(9):517. PubMed ID: 19180269
    [No Abstract]   [Full Text] [Related]  

  • 12. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.
    Russo AT; Grosenbach DW; Chinsangaram J; Honeychurch KM; Long PG; Lovejoy C; Maiti B; Meara I; Hruby DE
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):331-344. PubMed ID: 32882158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus.
    DeLaurentis CE; Kiser J; Zucker J
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0122622. PubMed ID: 36374026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection.
    Fatima M; Ahmed A; Murad MW; Afzal Z
    Eur J Intern Med; 2023 Jan; 107():105-106. PubMed ID: 36153182
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humans.
    Leeds JM; Fenneteau F; Gosselin NH; Mouksassi MS; Kassir N; Marier JF; Chen Y; Grosenbach D; Frimm AE; Honeychurch KM; Chinsangaram J; Tyavanagimatt SR; Hruby DE; Jordan R
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1136-43. PubMed ID: 23254433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vaccination, antiorthopoxvirus drug, and social cooperativity in a mathematical model of smallpox control.
    Finin P; Kosaraju A; Rose E; Rubin H
    Biosecur Bioterror; 2013 Mar; 11(1):59-72. PubMed ID: 23530860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
    Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Tecovirimat for the Treatment of Smallpox.
    Grosenbach DW; Honeychurch K; Rose EA; Chinsangaram J; Frimm A; Maiti B; Lovejoy C; Meara I; Long P; Hruby DE
    N Engl J Med; 2018 Jul; 379(1):44-53. PubMed ID: 29972742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monkeypox treatment: Current evidence and future perspectives.
    Khani E; Afsharirad B; Entezari-Maleki T
    J Med Virol; 2023 Jan; 95(1):e28229. PubMed ID: 36253931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Development against Smallpox: Present and Future.
    Delaune D; Iseni F
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.